1. Home
  2. EVO vs DAC Comparison

EVO vs DAC Comparison

Compare EVO & DAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • DAC
  • Stock Information
  • Founded
  • EVO 1993
  • DAC 1972
  • Country
  • EVO Germany
  • DAC Greece
  • Employees
  • EVO N/A
  • DAC N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • DAC Marine Transportation
  • Sector
  • EVO Health Care
  • DAC Consumer Discretionary
  • Exchange
  • EVO Nasdaq
  • DAC Nasdaq
  • Market Cap
  • EVO 1.5B
  • DAC 1.7B
  • IPO Year
  • EVO 2021
  • DAC 2006
  • Fundamental
  • Price
  • EVO $4.26
  • DAC $92.18
  • Analyst Decision
  • EVO Buy
  • DAC Strong Buy
  • Analyst Count
  • EVO 2
  • DAC 1
  • Target Price
  • EVO $5.90
  • DAC $105.00
  • AVG Volume (30 Days)
  • EVO 95.8K
  • DAC 75.2K
  • Earning Date
  • EVO 08-13-2025
  • DAC 08-04-2025
  • Dividend Yield
  • EVO N/A
  • DAC 3.69%
  • EPS Growth
  • EVO N/A
  • DAC N/A
  • EPS
  • EVO N/A
  • DAC 24.48
  • Revenue
  • EVO $851,944,444.00
  • DAC $1,013,968,000.00
  • Revenue This Year
  • EVO $10.08
  • DAC $2.55
  • Revenue Next Year
  • EVO $10.99
  • DAC N/A
  • P/E Ratio
  • EVO N/A
  • DAC $3.77
  • Revenue Growth
  • EVO 1.50
  • DAC 3.10
  • 52 Week Low
  • EVO $2.84
  • DAC $65.40
  • 52 Week High
  • EVO $5.64
  • DAC $92.64
  • Technical
  • Relative Strength Index (RSI)
  • EVO 55.61
  • DAC 64.01
  • Support Level
  • EVO $3.64
  • DAC $88.70
  • Resistance Level
  • EVO $4.36
  • DAC $92.64
  • Average True Range (ATR)
  • EVO 0.09
  • DAC 1.79
  • MACD
  • EVO -0.01
  • DAC 0.25
  • Stochastic Oscillator
  • EVO 86.11
  • DAC 92.53

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About DAC Danaos Corporation

Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include, HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia-Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.

Share on Social Networks: